Compare KHC & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KHC | STE |
|---|---|---|
| Founded | 1869 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Industrial Specialties |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.9B | 25.9B |
| IPO Year | N/A | 1992 |
| Metric | KHC | STE |
|---|---|---|
| Price | $24.55 | $251.66 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 17 | 9 |
| Target Price | $27.53 | ★ $268.25 |
| AVG Volume (30 Days) | ★ 12.8M | 620.7K |
| Earning Date | 10-29-2025 | 02-04-2026 |
| Dividend Yield | ★ 6.46% | 1.00% |
| EPS Growth | N/A | ★ 59.39 |
| EPS | N/A | ★ 6.97 |
| Revenue | ★ $25,164,000,000.00 | $5,702,415,000.00 |
| Revenue This Year | N/A | $9.61 |
| Revenue Next Year | $0.00 | $6.23 |
| P/E Ratio | ★ N/A | $36.08 |
| Revenue Growth | N/A | ★ 7.08 |
| 52 Week Low | $23.70 | $200.98 |
| 52 Week High | $33.35 | $268.60 |
| Indicator | KHC | STE |
|---|---|---|
| Relative Strength Index (RSI) | 46.24 | 43.63 |
| Support Level | $24.07 | $250.46 |
| Resistance Level | $24.98 | $255.31 |
| Average True Range (ATR) | 0.42 | 4.61 |
| MACD | 0.02 | -1.47 |
| Stochastic Oscillator | 39.47 | 16.01 |
In July 2015, Kraft merged with Heinz to create one of North America's largest food and beverage manufacturers. However, the firm now intends to split its global sauces arm from its North American grocery segment in the second half of 2026. Beyond its namesake brands, its portfolio includes Oscar Mayer, Velveeta, and Philadelphia. While the retail channel drives around 85% of its total sales, the firm also maintains a growing foodservice presence. Outside North America, Kraft Heinz's global reach encompasses a distribution network in Europe and emerging markets, which accounts for nearly 25% of its consolidated sales base. The company's products are sold in more than 190 countries and territories.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.